Cyberknife® Surgery at NYU Winthrop Hospital Cancer Center
At the Forefront of Cancer Care
Superior Cyberknife® Treatment at our State-of-the-Art Cyberknife Center
NYU Winthrop Hospital was the first medical institution in the New York Metropolitan region — and is among a select group in the country — to offer breakthrough CyberKnife radiosurgery, providing new hope to thousands of people with tumors and lesions once considered inoperable.
NYU Winthrop’s CyberKnife® team, among the most experienced in the world, was recently acknowledged at the International CyberKnife Meeting by Accuray as having the second largest experience worldwide in treating prostate cancer patients with CyberKnife.
The CyberKnife® Treatment Advantage
CyberKnife surgery is completely non-invasive and has transformed radiosurgeries of the brain, spine and soft-tissue (lungs, liver, pancreas and kidneys) into painless, bloodless outpatient procedures. Patients who undergo Cyberknife treatment typically resume normal activities soon after the procedure.
With high-tech, cruise-missile-guidance technology and ultra-flexible, computer-controlled robotics, CyberKnife delivers extraordinarily accurate, precisely targeted radiation to tumors throughout the body when radiation therapy is indicated. The beams can be sculpted to reach small, deeply imbedded, complex masses, minimizing damage to healthy tissue.
Giving new hope to thousands of people with tumors and lesions once considered inoperable, CyberKnife radiosurgery takes treatment of benign and malignant masses to a new level.
Cyberknife surgery advantages include:
- Treatment for tumors inoperable by conventional surgery or other stereotactic radiosurgery
- Additional treatment option for tumors that have received maximum allowed radiation
- Painless, bloodless and non-invasive
- High-dose radiation delivered accurately
- Ability to treat multiple tumors at different locations during a single session
- Healthy tissue unharmed
- No need for invasive, uncomfortable head frame or skull pins
- Full-body treatment capability CyberKnife is cleared by the FDA for treatment of tumors and lesions anywhere in the body when radiation therapy is indicated. However, patients should consult their physicians to determine if this treatment approach is right for them.
Our Cyberknife® Surgery Team
The Center’s multidisciplinary team, which collaborates to develop and implement comprehensive treatment plans tailored to each of our patient’s individual needs, includes:
- Radiation Oncologists
- Medical Oncologists
- Radiation Therapists
- Diagnostic Radiologists
Conditions Treated through Cyberknife® Surgery
- Primary and Metastatic Brain Tumors
- Prostate Cancer
- Spine Cancer
- Spinal Cord Tumors
- Soft Tissue Tumors (lung, kidney, liver, pancreas, prostate)
- Acoustic Neuromas
- Skull Base Tumors
- Pituitary tumors
- Recurrent and Residual Tumors
- Arteriovenous Malformations (AVMs)
- Functional Disorders, such as Trigeminal Neuralgia
Pastor Billy Richards shares the story of his Cyberknife
prostate cancer treatment at NYU Winthrop Hospital.